Pages that link to "Q77402825"
Jump to navigation
Jump to search
The following pages link to Antisense comes of age (Q77402825):
Displaying 14 items.
- Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs (Q24555118) (← links)
- Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo (Q30977445) (← links)
- Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination (Q33771816) (← links)
- Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease (Q33970374) (← links)
- Antisense cancer therapy: the state of the science (Q34107762) (← links)
- A cytosine analog that confers enhanced potency to antisense oligonucleotides (Q36441952) (← links)
- Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide (Q38329058) (← links)
- Polymorphisms in the large subunit of human RNA polymerase II as target for allele-specific inhibition (Q39542570) (← links)
- Single-injection ornithine decarboxylase-directed antisense therapy using atelocollagen to suppress human cancer growth (Q40167419) (← links)
- Targeted substrate degradation by an engineered double RING ubiquitin ligase (Q40714151) (← links)
- Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype (Q40732586) (← links)
- Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells (Q40772732) (← links)
- Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates (Q42802043) (← links)
- Phosphorothioate oligodeoxyribonucleotides inhibit ribonuclease L thereby disabling a mechanism of interferon action (Q77334638) (← links)